companydata.dkcompanydata.dk

Bios I Pharma ApS: Financial statements 2024

CVR: 32672620

Source: annual report 2024, Danish Business Authority

01/10/2023 – 30/09/2024

Bios I Pharma ApS (CVR 32672620) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 2,012,494 and a net result of DKK 1,732,448 compared with DKK 351,852 the year before. Equity in the 2024 report amounted to DKK 238,917. The solvency ratio was 6.1%.

Gross Profit
DKK 2,012,494
Profit/Loss
DKK 1,732,448
Equity
DKK 238,917
Total Assets
DKK 3,902,626
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-2M1.7M239K0
2023--1K352K-3M0
2022-48K10K-3.3M-
2021-775-68K-3.4M-
2019--610K-614K-3.2M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

Bios I Pharma ApS: The 2023 annual report is outApr 12, 2024

Bios I Pharma ApS has published its annual report for 2023. Gross profit came to DKK -1,282, and the net result was DKK 351,852.

Bios I Pharma ApS appoints new auditorJan 17, 2024

As of January 17, 2024, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of Bios I Pharma ApS.

Auditor steps down at Bios I Pharma ApSJan 17, 2024

As of January 17, 2024, TØNDER REVISION, GODKENDT REVISIONSAKTIESELSKAB has stepped down as auditor of Bios I Pharma ApS.

About Bios I Pharma ApS

Bios I Pharma ApS is a Danish company of the type Anpartsselskab based in Aarhus N, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named AC 01 ApS. The management consists of Henrik Beier Jessen. The company is owned by Beier Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -68,061 and a net result of DKK 206,285 compared with DKK 1,732,448 the year before. Equity in the 2025 report amounted to DKK 445,202.

Source: annual report 2025, Danish Business Authority